Table 2.
Control young | Acute EAE | Control old | Chronic EAE | |
---|---|---|---|---|
β1 | 1.73 ± 0.20 | 1.99 ± 0.11 | 1.70 ± 0.14 | 1.17 ± 0.05* |
β2 | 0.95 ± 0.10 | 0.78 ± 0.16 | 0.49 ± 0.05 | 0.59 ± 0.30 |
β5 | 1.57 ± 0.10 | 1.55 ± 0.06 | 1.25 ± 0.24 | 0.41 ± 0.10* |
iβ1 | 0.99 ± 0.30 | 2.37 ± 0.20* | 0.89 ± 0.09 | 0.72 ± 0.13 |
iβ2 | 2.03 ± 0.49 | 3.59 ± 0.50* | 1.45 ± 0.08 | 1.04 ± 0.22 |
iβ5 | 0.92 ± 0.06 | 1.69 ± 0.26* | 0.86 ± 0.07 | 1.02 ± 0.23 |
The concentration of each standard and immuno catalytic subunit in control and EAE cerebella was determined by western blot analysis (Fig. 1 and 2) using calibration curves made with increasing amounts of either purified standard proteasome or immunoproteasome. Values are the mean ± SEM of 3 animals per experimental group. Asterisks denote values that are significantly different (p<0.05) from control.